Lv1
20 积分 2025-03-24 加入
Update on dermatological toxicities of immune checkpoint inhibitors
1天前
已完结
Use of Suzetrigine, a Selective Sodium Channel Blocker, in Postoperative Pain Management for an Adolescent Patient With Hereditary Neuropathy: A Case Report
3天前
已完结
Patient-Reported Paresthesia After Administration of Suzetrigine: A Case Report
4天前
已完结
Sodium channel modulation as a therapeutic strategy for chemotherapy-induced peripheral neurotoxicity
4天前
已完结
Sodium Channel Inhibitors in Clinical Development for Pain Management: A Focused Review
4天前
已完结
Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know
1个月前
已关闭
Severe Asthma, Biologic Hypersensitivity and Inefficacy: Overcoming Treatment Barriers with Tezepelumab
1个月前
已完结
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literature
1个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
1个月前
已完结
Pharmacology Update: Suzetrigine: A Novel NaV1.8 Sodium Channel Inhibitor for Acute Pain Management
2个月前
已完结
皖公网安备34019202002308
